PKN3
Serine/threonine-protein kinase N3
Protein Summary
Contributes to invasiveness in malignant prostate cancer.
- ENST00000291906
- ENSP00000291906
- ENSG00000160447
- PKNBETA
- UTDP4-1
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
|---|---|---|---|
protein domain | 0.99 | ||
molecular function | 0.93 | ||
histone modification site profile | 0.74 | ||
transcription factor | 0.68 | ||
tissue sample | 0.57 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 26.38 (req: < 5)
Gene RIFs: 7 (req: <= 3)
Antibodies: 161 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 26.38 (req: >= 5)
Gene RIFs: 7 (req: > 3)
Antibodies: 161 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 10
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 3
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0